This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (23)  • Contact me when this article is cited  Related Content  • Related articles  • Similar articles in JAMA  Topic Collections  • Radiation Therapy  • Prostate Disease  • Oncology  • Prostate Cancer  • Alert me on articles by topic

Gerald W. Chodak, MD

JAMA. 1998;280:1008-1010.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Year after year, uncontrolled studies are published that attempt to compare the various treatments for localized prostate cancer. Almost uniformly, more questions are raised than answered and the debate goes on: Is surgery the most effective treatment? How comparable are surgery, external radiotherapy, and interstitial radiation delievered by implant (brachytherapy)? What is the marginal benefit of any treatment over conservative management followed by delayed hormone therapy? Two articles in this issue of THE JOURNAL, one by Albertsen et al¹ and one by D'Amico et al,² add more information but still leave physicians and their patients without definitive answers to these pressing questions.

The report by Albertsen et al¹ provides more definitive information about the long-term results based on a series of 767 men with clinically localized prostate cancer who had an average life expectancy of at least 10 years and who were managed conservatively, ie, with . . . [Full Text of this Article]

From the Prostate and Urology Center, Louis A. Weiss Memorial Hospital, Chicago, Ill.

RELATED ARTICLES

Biochemical Outcome After Radical Prostatectomy, External Beam Radiation Therapy, or Interstitial Radiation Therapy for Clinically Localized Prostate Cancer
Anthony V. D'Amico, Richard Whittington, S. Bruce Malkowicz, Delray Schultz, Kenneth Blank, Gregory A. Broderick, John E. Tomaszewski, Andrew A. Renshaw, Irving Kaplan, Clair J. Beard, and Alan Wein
JAMA. 1998;280(11):969-974.
ABSTRACT | FULL TEXT  

Competing Risk Analysis of Men Aged 55 to 74 Years at Diagnosis Managed Conservatively for Clinically Localized Prostate Cancer
Peter C. Albertsen, James A. Hanley, Donald F. Gleason, and Michael J. Barry
JAMA. 1998;280(11):975-980.
ABSTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Androgen Deprivation Therapy in Prostate Cancer and Metabolic Risk for Atherosclerosis
Shahani et al.
J. Clin. Endocrinol. Metab. 2008;93:2042-2049.
ABSTRACT | FULL TEXT  

Value-Induced Bias in Medical Decision Making
Levy and Hershey
Med Decis Making 2008;28:269-276.
ABSTRACT  

Prostatectomy, External Beam Radiation Therapy, or Brachytherapy for Localized Prostate Cancer
Fuller et al.
JAMA 1999;281:1583-1586.
FULL TEXT